ÇÐȸ¼Ò½Ä ¿ÜºÎ±â°üÇà»ç
2021 Çѱ¹µ¶¼ºÇÐȸ Ãá°è µ¶¼ºÇÐ ¿öÅ©¼¥ ¹× Ãá°è ±¹Á¦½ÉÆ÷Áö¿ò
» ÀÛ¼ºÀÚ : KSMCB |
» ÀÛ¼ºÀÏ : 2021-03-31 |
» Á¶È¸ : 712 |
|
2021 Çѱ¹µ¶¼ºÇÐȸ Ãá°è µ¶¼ºÇÐ ¿öÅ©¼¥ ¹× Ãá°è ±¹Á¦½ÉÆ÷Áö¿ò
•ÀÏÁ¤: 2021³â 5¿ù 13ÀÏ(¸ñ) - 5¿ù 14ÀÏ(±Ý) •Àå¼Ò: ¿Â¶óÀÎ °³ÃÖ •À§ÇØÁ¤º¸¼ÒÅë Æ÷·³ ÁÖÁ¦: Äڷγª19 ¹é½Å ¾ÈÀü¼º Æò°¡ ¹× À§ÇؼÒÅë •Ãá°è µ¶¼ºÇÐ ¿öÅ©¼¥ ÁÖÁ¦: ȯ°æ¼º À¯Çع°Áú À§Çؼº Æò°¡ ÃֽŠ¿¬±¸µ¿Çâ - Part 1 In Silico ¹æ¹ýÀ» È°¿ëÇÑ ÈÇй°Áú ¾ÈÀü¼º Æò°¡ - Part 2 ¹Ì¼¼¸ÕÁö À§Çؼº Æò°¡¹æ¹ý •Ãá°è ±¹Á¦½ÉÆ÷Áö¿ò ÁÖÁ¦: Current Issues in Toxicology - Session 1: (KIT Session) Strategic Approach in the COVID-19 Pandemic: Toxicological Perspective - Session 2: The Role of Multiple Omics Technology in the Future of Toxicology Research - Session 3: Current Perspectives in Microplastic Issues •¹®ÀÇó: Çѱ¹µ¶¼ºÇÐȸ »ç¹«±¹(E-mail: ksot@ksot.or.kr, Tel: 02-888-3248 )
•¼¼ºÎ»çÇ×Àº ÷ºÎÆÄÀÏÀ» È®ÀÎÇØ Áֽñ⠹ٶø´Ï´Ù
|
1 ·
2 ·
3 ·
4 ·
5 ·
6 ·
7 ·
8 ·
9 ·
10